567 related articles for article (PubMed ID: 12673892)
1. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
Koshy M; Berger D; Crow MK
J Clin Invest; 1996 Aug; 98(3):826-37. PubMed ID: 8698875
[TBL] [Abstract][Full Text] [Related]
3. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
Battaglia E; Biancone L; Resegotti A; Emanuelli G; Fronda GR; Camussi G
Am J Gastroenterol; 1999 Nov; 94(11):3279-84. PubMed ID: 10566730
[TBL] [Abstract][Full Text] [Related]
5. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.
McLellan AD; Sorg RV; Williams LA; Hart DN
Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193
[TBL] [Abstract][Full Text] [Related]
6. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.
Nakajima A; Azuma M; Kodera S; Nuriya S; Terashi A; Abe M; Hirose S; Shirai T; Yagita H; Okumura K
Eur J Immunol; 1995 Nov; 25(11):3060-9. PubMed ID: 7489744
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus.
Harigai M; Hara M; Fukasawa C; Nakazawa S; Kawaguchi Y; Kamatani N; Kashiwazaki S
Lupus; 1999; 8(3):227-33. PubMed ID: 10342716
[TBL] [Abstract][Full Text] [Related]
8. Cross-species costimulation: relative contributions of CD80, CD86, and CD40.
Rogers NJ; Jackson IM; Jordan WJ; Hawadle MA; Dorling A; Lechler RI
Transplantation; 2003 Jun; 75(12):2068-76. PubMed ID: 12829914
[TBL] [Abstract][Full Text] [Related]
9. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
Desai-Mehta A; Lu L; Ramsey-Goldman R; Datta SK
J Clin Invest; 1996 May; 97(9):2063-73. PubMed ID: 8621796
[TBL] [Abstract][Full Text] [Related]
10. CD40 ligand is expressed and functional on activated neonatal T cells.
Splawski JB; Nishioka J; Nishioka Y; Lipsky PE
J Immunol; 1996 Jan; 156(1):119-27. PubMed ID: 8598451
[TBL] [Abstract][Full Text] [Related]
11. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
12. CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice.
Mathur M; Herrmann K; Qin Y; Gulmen F; Li X; Krimins R; Weinstock J; Elliott D; Bluestone JA; Padrid P
Am J Respir Cell Mol Biol; 1999 Oct; 21(4):498-509. PubMed ID: 10502560
[TBL] [Abstract][Full Text] [Related]
13. B7-1 (CD80) and B7-2 (CD 86) expression in human tubular epithelial cells in vivo and in vitro.
Niemann-Masanek U; Mueller A; Yard BA; Waldherr R; van der Woude FJ
Nephron; 2002; 92(3):542-56. PubMed ID: 12372936
[TBL] [Abstract][Full Text] [Related]
14. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers.
Han S; Hathcock K; Zheng B; Kepler TB; Hodes R; Kelsoe G
J Immunol; 1995 Jul; 155(2):556-67. PubMed ID: 7541819
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of prostaglandins E1 and E2 on lipopolysaccharide-induced adhesion molecule expression on human monocytes.
Takahashi HK; Iwagaki H; Tamura R; Katsuno G; Xue D; Sugita S; Mori S; Yoshino T; Tanaka N; Nishibori M
Eur J Pharmacol; 2005 Apr; 512(2-3):223-30. PubMed ID: 15840408
[TBL] [Abstract][Full Text] [Related]
16. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
17. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
[TBL] [Abstract][Full Text] [Related]
18. Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector.
Ziller C; Stoeckel F; Boon L; Haegel-Kronenberger H
Gene Ther; 2002 May; 9(9):537-46. PubMed ID: 11973629
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma differentially regulates CD80 (B7-1) and CD86 (B7-2/B70) expression on human Langerhans cells.
Yokozeki H; Katayama I; Ohki O; Arimura M; Takayama K; Matsunaga T; Satoh T; Umeda T; Azuma M; Okumura K; Nishioka K
Br J Dermatol; 1997 Jun; 136(6):831-7. PubMed ID: 9217813
[TBL] [Abstract][Full Text] [Related]
20. [A study of costimulatory molecules in allergic allergic rhinitis patients].
Zhu R; Liu G; Li W; Wang Z; Chen H; Zhang W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep; 22(17):780-2, 784. PubMed ID: 19086656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
